Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
This study has been completed.
Study NCT00259831   Information provided by Afexa Life Sciences Inc

First Received on November 29, 2005.   Last Updated on June 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Upper Respiratory Infection
Additional conditions recognized in this trial
Common Cold
Respiratory Tract Infections
More general conditions related to this trial
Infection
Picornaviridae Infections
Respiratory Tract Diseases
RNA Virus Infections
Virus Diseases
Sponsors listed in this trial
CV Technologies
Capital Health, Canada


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services